Read-Gene SA operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Read-Gene SA with three other
miscellaneous service companies in Europe:
Medical Prognosis Institute A/S
sales of 4.99 million Danish Kroner [US$750,307.69 ]
Realm Therapeutics PLC
of the United Kingdom
(£644,819.07 [US$839,606.02 ]
of which 100%
was Health Sciences), and
Oryzon Genomics Sa
based in Spain
(735,312.00 Euro [US$822,497.94 ]
Read-Gene SA reported sales of 2.98 million Polish New Zlotys (US$794.55 thousand)
December of 2016.
increase of 36.5%
versus 2015, when the company's sales were 2.19 million Polish New Zlotys.
This was the third consecutive year of growth at Read-Gene SA.